Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 15/11/2011
PIL Arcoxia 30mg, 60 mg, 90 mg & 120 mg Film-coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 17/08/2011 and displayed until 15/11/2011
Reasons for adding or updating:
  • Change to Further Information section
Updated on 03/03/2011 and displayed until 17/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to side-effects
Updated on 29/06/2010 and displayed until 03/03/2011
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 23/09/2009 and displayed until 29/06/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/11/2008 and displayed until 23/09/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to dosage and administration
Updated on 14/05/2008 and displayed until 04/11/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 22/01/2008 and displayed until 14/05/2008
Reasons for adding or updating:
  • Introduction of new strength
  • Change due to user-testing of patient information
  • Change due to harmonisation of patient information leaflet
Updated on 04/09/2007 and displayed until 22/01/2008
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
Updated on 02/08/2007 and displayed until 04/09/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 24/04/2006 and displayed until 02/08/2007
Reasons for adding or updating:
  • Change to appearance of the medicine
Updated on 05/01/2006 and displayed until 24/04/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change of contra-indications
Updated on 01/06/2005 and displayed until 05/01/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 21/01/2005 and displayed until 01/06/2005
Reasons for adding or updating:
  • Change to side-effects
Updated on 23/07/2004 and displayed until 21/01/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 21/08/2002 and displayed until 23/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 15/04/2002 and displayed until 21/08/2002
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  etoricoxib